Effectiveness of the CHESS eHealth Cancer Support Intervention in Population-based Care

NCT ID: NCT01033162

Last Updated: 2019-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

368 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study's aim is to provide information about the clinical and business cases for comprehensive interactive cancer communication systems (ICCS) in the context of real world use for cancer care.

This study will be conducted within the Kaiser Permanente Northwest (KPNW) healthcare system. Outcomes for this study include amount of ICCS use and women's ratings of cancer information competence, perceived social support, and emotional well being. Secondary outcomes will include healthcare utilization, cost-effectiveness, and clinician ratings of healthcare visits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

A group using a Basic ICCS provided by KPNW

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

A group using an enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)

Group Type EXPERIMENTAL

Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)

Intervention Type BEHAVIORAL

Half of the participating women will be randomly assigned to use an informative but static website (Basic ICCS), and half will be offered a fully interactive CHESS (Enhanced ICCS + the Basic ICCS). Study outcome data will be gathered from patients, clinicians, and the healthcare system (i.e., from the electronic medical record: EMR) for at least 8 months after study entry. We propose that the Enhanced ICCS relative to the Basic ICCS, will:

* Improve patients' sense of cancer information competence (perceived ability to obtain and use relevant information)
* Reduce patients' negative affect and increase their emotional well being
* Improve patients' sense of social support
* Improve patients' health self-efficacy
* Improve patients' ratings of experience with cancer specialty care services
* Improve patients' health related quality of life (HRQL)
* Improve clinicians' ratings of quality of patient contacts
* Reduce healthcare utilization and costs (obtained via the EMR)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enhanced ICCS with KPNW web resources and the Comprehensive Health Enhancement Support System (CHESS.)

Half of the participating women will be randomly assigned to use an informative but static website (Basic ICCS), and half will be offered a fully interactive CHESS (Enhanced ICCS + the Basic ICCS). Study outcome data will be gathered from patients, clinicians, and the healthcare system (i.e., from the electronic medical record: EMR) for at least 8 months after study entry. We propose that the Enhanced ICCS relative to the Basic ICCS, will:

* Improve patients' sense of cancer information competence (perceived ability to obtain and use relevant information)
* Reduce patients' negative affect and increase their emotional well being
* Improve patients' sense of social support
* Improve patients' health self-efficacy
* Improve patients' ratings of experience with cancer specialty care services
* Improve patients' health related quality of life (HRQL)
* Improve clinicians' ratings of quality of patient contacts
* Reduce healthcare utilization and costs (obtained via the EMR)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All subjects must be within 2 months of their primary breast cancer diagnosis,
* All subjects must be at least 18 years of age

Exclusion Criteria

* Illiterate
* Homeless
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Timothy Baker

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaiser Permanente Northwest

Portland, Oregon, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

https://cancer.wisc.edu/

University of Wisconsin Carbone Cancer Center

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5P50CA095817

Identifier Type: NIH

Identifier Source: secondary_id

View Link

XP08323

Identifier Type: OTHER

Identifier Source: secondary_id

NCI-2013-01101

Identifier Type: REGISTRY

Identifier Source: secondary_id

A534253

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/MEDICINE/MEDICINE*G

Identifier Type: OTHER

Identifier Source: secondary_id

H-2008-0222

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mentor Integration Study
NCT00468468 COMPLETED NA